JP2005519085A5 - - Google Patents

Download PDF

Info

Publication number
JP2005519085A5
JP2005519085A5 JP2003571261A JP2003571261A JP2005519085A5 JP 2005519085 A5 JP2005519085 A5 JP 2005519085A5 JP 2003571261 A JP2003571261 A JP 2003571261A JP 2003571261 A JP2003571261 A JP 2003571261A JP 2005519085 A5 JP2005519085 A5 JP 2005519085A5
Authority
JP
Japan
Prior art keywords
formula
alkyl
compound
hydrogen
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003571261A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005519085A (ja
JP4486363B2 (ja
Filing date
Publication date
Priority claimed from DE10208987A external-priority patent/DE10208987A1/de
Application filed filed Critical
Publication of JP2005519085A publication Critical patent/JP2005519085A/ja
Publication of JP2005519085A5 publication Critical patent/JP2005519085A5/ja
Application granted granted Critical
Publication of JP4486363B2 publication Critical patent/JP4486363B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003571261A 2002-02-28 2003-02-14 置換3−フェニル−5−アルコキシ−1,3,4−オキサジアゾール−2−オン、これの製造方法および薬剤での使用 Expired - Fee Related JP4486363B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10208987A DE10208987A1 (de) 2002-02-28 2002-02-28 Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxidiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen
PCT/EP2003/001484 WO2003072555A1 (de) 2002-02-28 2003-02-14 Substituierte 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-one sowie ihre herstellung und verwendung in arzneistoffen

Publications (3)

Publication Number Publication Date
JP2005519085A JP2005519085A (ja) 2005-06-30
JP2005519085A5 true JP2005519085A5 (enExample) 2006-03-30
JP4486363B2 JP4486363B2 (ja) 2010-06-23

Family

ID=27740558

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003571261A Expired - Fee Related JP4486363B2 (ja) 2002-02-28 2003-02-14 置換3−フェニル−5−アルコキシ−1,3,4−オキサジアゾール−2−オン、これの製造方法および薬剤での使用

Country Status (22)

Country Link
EP (1) EP1480960B1 (enExample)
JP (1) JP4486363B2 (enExample)
KR (1) KR20040095240A (enExample)
CN (1) CN1639137A (enExample)
AR (1) AR038701A1 (enExample)
AT (1) ATE557012T1 (enExample)
AU (1) AU2003226977A1 (enExample)
BR (1) BR0307921A (enExample)
CA (1) CA2477031A1 (enExample)
CO (1) CO5611146A2 (enExample)
DE (1) DE10208987A1 (enExample)
HR (1) HRP20040782A2 (enExample)
HU (1) HUP0402671A3 (enExample)
IL (1) IL163683A0 (enExample)
MA (1) MA27172A1 (enExample)
MX (1) MXPA04007960A (enExample)
NO (1) NO20044090L (enExample)
PE (1) PE20030928A1 (enExample)
PL (1) PL370423A1 (enExample)
RU (1) RU2004128933A (enExample)
TW (1) TW200400951A (enExample)
WO (1) WO2003072555A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074822B2 (en) 2004-02-23 2006-07-11 Solvay Pharmaceuticals Gmbh Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them
RU2007119315A (ru) 2004-10-25 2008-11-27 Зольвай Фармасьютиклз Гмбх (De) Фармацевтические композиции, содержащие антагонисты каннабиноидного рецептора св1 и открыватели калиевых каналов, предназначенные для лечения сахарного диабета типа i, ожирения и связанных с ними состояний
TW200932732A (en) * 2007-12-27 2009-08-01 Bial Portela & Companhia S A 5-O-substituted 3-N-phenyl-1,3,4-oxadiazolones for medical use
AR074978A1 (es) 2008-12-23 2011-03-02 Bial Portela & Ca Sa 3-n-aril-1,3,4-oxadiazolonas 5-o-sustituidas para uso en el tratamiento del dolor y procedimiento de obtencion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19942354A1 (de) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
HRP20020732A2 (en) * 2000-03-07 2004-12-31 Aventis Pharma Gmbh Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase

Similar Documents

Publication Publication Date Title
JP2005519932A5 (enExample)
JP2009519226A5 (enExample)
JP2005053931A5 (enExample)
JP2008543764A5 (enExample)
JP2005535586A5 (enExample)
JP2004137288A5 (enExample)
JP2005526076A5 (enExample)
JP2010504908A5 (enExample)
JP2008504265A5 (enExample)
JP2007502804A5 (enExample)
JP2008526996A5 (enExample)
JP2002513793A5 (enExample)
JP2009500423A5 (enExample)
JP2006507355A5 (enExample)
JP2009519903A5 (enExample)
RU2318812C2 (ru) Производные изохинолина
JP2005517008A5 (enExample)
JP2005517677A5 (enExample)
JP2007532627A5 (enExample)
RU2005121908A (ru) Производные зн-хиназолин-4-она
JP2004523478A5 (enExample)
JP2004525178A5 (enExample)
JP2005502636A5 (enExample)
JP2007532628A5 (enExample)
JP2010535751A5 (enExample)